Publications (50) Publications de IRUNE RUIZ DÍAZ

2024

  1. Biphasic papillary (biphasic squamoid alveolar) renal cell carcinoma: a clinicopathologic and molecular study of 17 renal cell carcinomas including 10 papillary adenomas

    Virchows Archiv, Vol. 484, Núm. 3, pp. 441-449

  2. Müllerian adenosarcoma with sarcomatous overgrowth and heterologous elements: A case report and literature review

    Revista Espanola de Patologia

2023

  1. Metastatic solid tumors to the testis: a clinicopathologic evaluation of 157 cases from an international collaboration

    Human Pathology, Vol. 139, pp. 37-46

  2. Metastatic solid tumours to the penis: a clinicopathologic evaluation of 109 cases from an international collaboration

    Histopathology, Vol. 83, Núm. 1, pp. 31-39

  3. OSNA Total Tumor Load for the Prediction of Axillary Involvement in Breast Cancer Patients: Should We use Different Thresholds According to the Intrinsic Molecular Subtype? MOTTO Study

    Clinical Pathology, Vol. 16

  4. Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with non-metastatic breast cancer at diagnosis and 2 years after

    Quality of Life Research, Vol. 32, Núm. 4, pp. 989-1003

  5. microRNA sequencing for biomarker detection in the diagnosis, classification and prognosis of Diffuse Large B Cell Lymphoma

    Scientific reports, Vol. 13, Núm. 1, pp. 12159

2022

  1. Author Correction: PR-LncRNA signature regulates glioma cell activity through expression of SOX factors (Scientific Reports, (2018), 8, 1, (12746), 10.1038/s41598-018-30836-5)

    Scientific Reports

  2. Chaperone-Mediated Autophagy Controls Proteomic and Transcriptomic Pathways to Maintain Glioma Stem Cell Activity

    Cancer Research, Vol. 82, Núm. 7, pp. 1283-1297

2021

  1. Factors that Influence Treatment Delay for Patients with Breast Cancer

    Annals of Surgical Oncology, Vol. 28, Núm. 7, pp. 3714-3721

  2. One-step nucleic acid amplification (Osna) of sentinel lymph node in early-stage endometrial cancer: Spanish multicenter study (endo-osna)

    Cancers, Vol. 13, Núm. 17

  3. PD-L1 testing based on the SP142 antibody in metastatic triple-negative breast cancer: Summary of an expert round-table discussion

    Future Oncology, Vol. 17, Núm. 10, pp. 1209-1218

2020

  1. High-grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication—a comprehensive clinical, radiographic, pathologic, and genomic analysis

    Brain Pathology, Vol. 30, Núm. 1, pp. 46-62

  2. Methylation of MGMT promoter does not predict response to temozolomide in patients with glioblastoma in Donostia Hospital

    Scientific Reports, Vol. 10, Núm. 1

  3. Reply to: Comment to: Helicobacter pylori seroprevalence in Spain: influence of adult and childhood sociodemographic factors

    European Journal of Cancer Prevention

2019

  1. Helicobacter pylori seroprevalence in Spain: Influence of adult and childhood sociodemographic factors

    European Journal of Cancer Prevention, Vol. 28, Núm. 4, pp. 294-303

  2. Liquid biopsy in glioblastoma: Opportunities, applications and challenges

    Cancers, Vol. 11, Núm. 7

  3. Predictive model of breast cancer metastasis in axillary non-sentinel lymph nodes. Emergent variables. The MOTTO study, part I

    Revista de Senologia y Patologia Mamaria, Vol. 32, Núm. 4, pp. 127-132

  4. Vemurafenib as first-line therapy in BRAF -V600E-mutant Erdheim-Chester disease with CNS involvement

    BMJ Case Reports, Vol. 12, Núm. 11

2018

  1. Indirect costs associated with glioblastoma: Experience at one hospital

    Neurologia, Vol. 33, Núm. 2, pp. 121-128